Meredith B Brooks
Meredith Brooks, PhD
Instructor in Global Health and Social Medicine, Harvard Medical School

Meredith Brooks, PhD, MPH is an Instructor in Global Health and Social Medicine at Harvard Medical School. She has been in the Department since 2011 working on a wide variety of tuberculosis (TB) research projects, including international clinical trials to evaluate the safety and efficacy of TB treatments. Dr. Brooks obtained her PhD in Population Health in 2017, and previously an MPH in 2013, from Northeastern University. Her dissertation work was dedicated to applying more robust methodologies to reduce bias in the analyses of observational cohort data-- specifically, TB treatment cohort analyses. After graduating she completed a two-year postdoctoral fellowship under Professor Mercedes Becerra, focusing on TB epidemiology.

Her research interests include identifying effective implementation strategies to detect exposed individuals, with a particular interest in children, at high-risk of developing TB disease. Aims of her current projects include:

  1. to characterize the geospatial heterogeneity of TB, drug resistance, and associated individual- and neighborhood-level risk factors to inform targeted screening interventions and resource allocation;
  2. identify risk factors for TB infection, TB disease progression, and poor treatment outcomes in children and adolescents, for whom guidelines are deficient; and
  3. refinement of diagnostic algorithms to better categorize children with TB disease and infection.
Pharmacokinetics of Levofloxacin in Children Treated for Exposure to Drug-Resistant Tuberculosis.
Authors: Authors: Malik AA, Brooks MB, Siddiqui S, Fuad J, Peloquin CA, Amanullah F, Jaswal M, Becerra MC, Hussain H, Yuen CM.
Antimicrob Agents Chemother
View full abstract on Pubmed
Reply to te Brake et al.: Conflicting Findings on an Intermediate Dose of Rifampicin for Pulmonary Tuberculosis.
Authors: Authors: Velásquez GE, Brooks MB, Coit JM, Sánchez Garavito E, Calderón RI, Jiménez J, Tintaya K, Peloquin CA, Osso E, Lecca L, Davies GR, Mitnick CD.
Am J Respir Crit Care Med
View full abstract on Pubmed
Establishing a relationship between the effect of caffeine and duration of endurance athletic time trial events: A systematic review and meta-analysis.
Authors: Authors: Shen JG, Brooks MB, Cincotta J, Manjourides JD.
J Sci Med Sport
View full abstract on Pubmed
Risk factors for unsuccessful tuberculosis treatment outcomes in children.
Authors: Authors: Hamid M, Brooks MB, Madhani F, Ali H, Naseer MJ, Becerra M, Amanullah F.
PLoS One
View full abstract on Pubmed
Evaluation of GenoType MTBDRplus for the detection of drug-resistant Mycobacterium tuberculosis on isolates from Karachi, Pakistan.
Authors: Authors: Siddiqui S, Brooks MB, Malik AA, Fuad J, Nazish A, Bano S, Becerra MC, Hussain H.
PLoS One
View full abstract on Pubmed
Use of predicted vital status to improve survival analysis of multidrug-resistant tuberculosis cohorts.
Authors: Authors: Brooks MB, Keshavjee S, Gelmanova I, Zemlyanaya NA, Mitnick CD, Manjourides J.
BMC Med Res Methodol
View full abstract on Pubmed
Efficacy and Safety of High-Dose Rifampin in Pulmonary Tuberculosis. A Randomized Controlled Trial.
Authors: Authors: Velásquez GE, Brooks MB, Coit JM, Pertinez H, Vargas Vásquez D, Sánchez Garavito E, Calderón RI, Jiménez J, Tintaya K, Peloquin CA, Osso E, Tierney DB, Seung KJ, Lecca L, Davies GR, Mitnick CD.
Am J Respir Crit Care Med
View full abstract on Pubmed